Vanda Pharmaceuticals (VNDA) Tax Rate (2010 - 2026)
Vanda Pharmaceuticals (VNDA) posted Tax Rate of 0.21% for Q1 2026, up 99.92% sequentially from 271.53% in Q4 2025, and down 2128.0% YoY from 0.01% in Q1 2025.
Analysis
Vanda Pharmaceuticals (VNDA) Tax Rate (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals has reported Tax Rate for 12 years, with the latest figure at 0.21% in Q1 2026.
- Quarterly Tax Rate fell 2128.0% year-over-year to 0.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 59.98% (down 8046.0% YoY) and the FY2025 annual result came in at 59.02%, down 7656.0% from the prior year.
- Tax Rate grew to 0.21% in Q1 2026 per VNDA's latest filing, from 271.53% in the prior quarter.
- Over five years, Tax Rate peaked at 214.17% in Q3 2023 and troughed at 271.53% in Q4 2025.
- A 5-year average of 13.52% and a median of 21.07% in 2025 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2023 and 2025: Tax Rate jumped 17388 bps in 2023, then sank 29648 bps in 2025.
- Over 5 years, Tax Rate stood at 28.63% in 2022, then plunged by 254 bps to 43.95% in 2023, then soared by 157 bps to 24.95% in 2024, then tumbled by 1188 bps to 271.53% in 2025, then soared by 100 bps to 0.21% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.21%, 271.53%, and 20.43% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn | -0.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.21% |
| Mar 31, 2026 | -0.30% |
| Dec 31, 2025 | -271.64% |
| Sep 30, 2025 | 20.44% |
| Jun 30, 2025 | 22.07% |
| Mar 31, 2025 | 21.14% |
| Dec 31, 2024 | 24.40% |
| Sep 30, 2024 | 14.73% |
| Jun 30, 2024 | 18.13% |
| Mar 31, 2024 | 11.11% |
| Dec 31, 2023 | -43.95% |
| Sep 30, 2023 | 250.00% |
| Jun 30, 2023 | 42.44% |
| Mar 31, 2023 | 41.61% |
| Dec 31, 2022 | 28.35% |
| Sep 30, 2022 | 40.29% |
| Jun 30, 2022 | 32.08% |
| Mar 31, 2022 | 14.99% |
| Dec 31, 2021 | 17.56% |
| Sep 30, 2021 | 27.98% |